Antihyperalgesic effects of imidazoline<scp>I</scp>₂receptor ligands in rat models of inflammatory and neuropathic pain

Abstract

Imidazoline I2 receptor ligands have antihyperalgesic effects in rat models of inflammatory and neuropathic pain and may represent a new class of pharmacotherapeutics for the management of chronic pain.